As shown in Fig. 2e–h, glioblastoma cells subjected to treatment with the combination of CUSP9v3 and TTFields showed a significant increase of the fraction of Annexin V‐positive (apoptotic) cells when compared to either treatment alone. This evidence concerns the gene ANXA5 and glioblastoma.